In 2001, under the leadership of Academician of the Russian Academy of Medical Sciences V.I. Pokrovsky, a new edition of the domestic clinical classification HIV infections.
Clinical classification of HIV infection:

Stage 1– “incubation stage” – the period from the moment of infection to the appearance of the body’s reaction in the form of clinical manifestations acute infection and/or antibody production. Its duration usually ranges from 3 weeks to 3 months, but in isolated cases it can last up to a year. During this period, HIV actively multiplies, but there are no clinical manifestations of the disease and antibodies to HIV have not yet been detected. Therefore, the diagnosis of HIV infection at this stage is traditional laboratory method cannot be installed. It can only be suspected on the basis of epidemiological data and confirmed by laboratory research detection of human immunodeficiency virus, its antigens, and nucleic acids in the patient’s serum.
Stage 2– “stage of primary manifestations”, is associated with the manifestation of the body’s primary response to the introduction and replication of HIV in the form of clinical manifestations and/or the production of antibodies. The stage of primary manifestations of HIV infection can have several course options:
2A – “asymptomatic”, characterized by the absence of any clinical manifestations of HIV infection. The body's response to the introduction of HIV is manifested only by the production of antibodies.
2B – “acute infection without secondary diseases”, manifested by a variety of clinical symptoms. The most frequently recorded are fever, rashes on the skin and mucous membranes (urticarial, papular, petechial), increased lymph nodes, pharyngitis. An enlarged liver, spleen, and diarrhea may occur.
Sometimes aseptic meningitis develops, manifested by meningeal syndrome. In this case, lumbar puncture usually produces unchanged cerebrospinal fluid flowing under high blood pressure, occasionally there is slight lymphocytosis. Similar clinical symptoms can be observed in many infectious diseases, especially with so-called childhood infections.
Sometimes this variant of the course is called mononucleosis-like or rubella-like syndrome. In the blood of patients during this period, wide-plasma lymphocytes - mononuclear cells - can be detected, which further enhances the similarity of this variant of the course of HIV infection with infectious mononucleosis.
Vivid mononucleosis-like or rubella-like symptoms are observed in 15-30% of patients. The rest have 1-2 of the above symptoms in any combination. Some patients may experience lesions of an autoimmune nature. With this course of the stage of primary manifestations, a transient decrease in the level of CD4 lymphocytes is often observed.
2B – “acute infection with secondary diseases”, characterized by a significant decrease in the level of CD4 lymphocytes. As a result, against the background of immunodeficiency, secondary diseases of various etiologies appear (candidiasis, herpetic infection, etc.). Their manifestations, as a rule, are mild, short-term, respond well to therapy, but can be severe (candidal esophagitis, Pneumocystis pneumonia) and in rare cases, even death is possible.
In general, the stage of primary manifestations, which occurs in the form of acute infection (2B and 2C), is recorded in 50-90% of patients with HIV infection. The onset of the stage of primary manifestations, which occurs in the form of an acute infection, is usually noted in the first 3 months after infection. It can precede seroconversion, that is, the appearance of antibodies to HIV. Therefore, at the first clinical symptoms, antibodies to HIV proteins and glycoproteins may not be detected in the patient’s serum.
The duration of clinical manifestations in the second stage can vary from several days to several months, but they are usually recorded within 2-3 weeks. Clinical symptoms of the stage of primary manifestations of HIV infection can recur.
In general, the duration of the stage of primary manifestations of HIV infection is one year from the onset of symptoms of acute infection or seroconversion. In prognostic terms, the asymptomatic course of the stage of primary manifestations of HIV infection is more favorable. The more severe and longer (more than 14 days) this stage proceeded, the greater the likelihood of rapid progression of HIV infection.
The stage of primary manifestations of HIV infection in the vast majority of patients becomes subclinical, but in some patients it can immediately pass into the stage of secondary diseases.
Stage 3– “subclinical stage” is characterized by a slow increase in immunodeficiency, which is associated with compensation of the immune response due to modification and excessive reproduction of CD4 cells. The rate of HIV reproduction during this period, compared to the stage of primary manifestations, slows down.
The main clinical manifestation of the subclinical stage is persistent generalized lymphadenopathy (PGL). It is characterized by an enlargement of at least two lymph nodes, in at least two unrelated groups (not counting the inguinal ones), in adults to a size in diameter of more than 1 cm, in children - more than 0.5 cm, persisting for at least 3 years. -x months. Upon examination, usually the lymph nodes are elastic, painless, not fused with the surrounding tissue, and the skin over them is not changed.
Enlarged lymph nodes at this stage may not meet the criteria for PGL or may not be registered at all. On the other hand, such changes in the lymph nodes can be observed even more late stages HIV infections, in some cases, they occur throughout the entire disease, but in the subclinical stage, enlarged lymph nodes are the only clinical manifestation.
The duration of the subclinical stage ranges from 2-3 to 20 or more years, but on average it lasts 6-7 years. The rate of decrease in the level of CD4 lymphocytes during this period averages 0.05-0.07x10 9 /l per year.
Stage 4– “stage of secondary diseases”, is associated with depletion of the CD4 cell population due to ongoing HIV replication. As a result, against the background of significant immunodeficiency, infectious and/or oncological secondary diseases develop. Their presence determines the clinical picture of the stage of secondary diseases.
Depending on the severity of secondary diseases, stages 4A, 4B, 4B are distinguished:
4A usually develops 6-10 years after infection. It is characterized by bacterial, fungal and viral lesions of the mucous membranes and skin, inflammatory diseases of the upper respiratory tract. Typically, stage 4A develops in patients with a CD4 lymphocyte count of 0.5-0.35x10 9 /L (in healthy individuals, the CD4 lymphocyte count ranges from 0.6-1.9x10 9 /L).
4B most often occurs 7-10 years after infection. Skin lesions during this period are deeper in nature and tend to be protracted. Lesions begin to develop internal organs. Weight loss, fever, localized Kaposi's sarcoma, peripheral nervous system. Typically, stage 4B develops in patients with a CD4 lymphocyte count of 0.35-0.2x10 9 /L.
4B is predominantly detected 10-12 years after infection. It is characterized by the development of severe, life-threatening secondary diseases, their generalized nature, and damage to the central nervous system. Typically, stage 4B occurs when the CD4 count is less than 0.2x10 9 /L. Despite the fact that the transition of HIV infection to the stage of secondary diseases is a manifestation of the depletion of the protective reserves of the body of an infected person, this process is reversible (at least for some time). Spontaneously or as a result of ongoing therapy clinical manifestations secondary diseases may disappear. Therefore, in the stage of secondary diseases, phases of progression (in the absence of antiretroviral therapy or against the background of antiretroviral therapy) and remission (spontaneous, after previously conducted antiretroviral therapy or against the background of antiretroviral therapy) are distinguished.
Stage 5– “terminal stage”, manifested by the irreversible course of secondary diseases. Even adequately administered antiretroviral therapy and treatment of secondary diseases are ineffective. As a result, the patient dies within a few months. At this stage, the CD4 cell count is usually below 0.05x10 9 /L.
It should be noted that clinical course HIV infections are very diverse. The given data on the duration of individual stages of the disease are averaged and may have significant fluctuations. The sequence of progression of HIV infection through all stages of the disease is not necessary. For example, the latent stage can, when a patient develops Pneumocystis pneumonia, go directly to stage 4B, bypassing stages 4A and 4B. There are cases when the latent stage directly passed into the terminal stage.
The duration of HIV infection varies widely. Average duration disease from the moment of HIV infection to the development of the final stage of HIV infection (AIDS itself) ranges from 5-8 to 10-12 years, although some patients live 15 years or more.
The fastest progression of the disease from the moment of infection to death is described, which was 28 weeks.
The duration of the disease depends on the type of virus and the individual characteristics of the human body (the body’s susceptibility to the virus, the presence of concomitant diseases, habitual intoxications, etc.). Thus, when infected with HIV type 2, the disease progresses somewhat more slowly. The older you are when you become infected with HIV, the faster the disease usually progresses.
Intravenous administration of psychoactive substances is often accompanied by the development of severe bacterial infections(abscesses, phlegmons, pneumonia, endocarditis, sepsis, tuberculosis, etc.), which can also occur with a normal content of CD4 lymphocytes. At the same time, the presence of these lesions contributes to a more rapid progression of HIV infection.
The use of modern antiretroviral therapy regimens can significantly increase the duration and improve the quality of life of patients with HIV infection.
Belyaeva Valentina Vladimirovna,

Pokrovsky Vadim Valentinovich,
Professor, Academician of the Russian Academy of Medical Sciences, Head of the Russian Federal Scientific and Methodological Center for the Prevention and Control of AIDS
Kravchenko Alexey Viktorovich,
Doctor of Medical Sciences, leading researcher at the Russian Federal Scientific and Methodological Center for the Prevention and Control of AIDS